[1] 丁芳,杨朝,耑冰,等. 慢性阻塞性肺病相关肺动脉高压的临床特
点及压力相关因素分析[J].宁夏医学杂志,2014,36(3):235-238.
[2] 周凤丽,黄静,李洪涛,等.莫西沙星与左氧氟沙星治疗AECOPD
的对比研究[J].中国抗生素杂志,2011,36(7):553-556.
[3] 中华医学会呼吸病学分会慢性阻塞性肺疾病组.慢性阻塞性肺疾
病诊治指南(2007 年修订版)[J]. 中华结核和呼吸杂志,2007,30
(1):8-17.
[4] Vorster MJ, Koegelenberg CF. Lung volume reduction in
chronic obstructive pulmonary disease [J]. S Afr Med J,
2015,105(9):791.
[5] Attia EF, McGinnis KA, Feemster LC, et al. Association
of COPD With Risk for Pulmonary Infections Requiring
Hospitalization in HIV-Infected Veterans [J]. J Acquir Immune
Defic Syndr, 2015,70(3):280-288.
[6] Gaude GS, Rajesh BP, Chaudhury A, et al. Outcomes associated
with acute exacerbations of chronic obstructive pul
monary disorder requiring hospitalization [J]. Lung India,
2015,32(5):465-472.
[7] 伏俊,房三友,闻寅,等. 美罗培南联合莫西沙星治疗慢性阻塞性
肺病并发感染性肺炎的疗效分析[J].中华实验和临床感染病杂志
(电子版),2015,(1):73-76.